By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker said Thursday after the close of the market that it expects to report total revenue for the fourth quarter of more than $355 million.

The updated preliminary results follow its Jan. 13 announcement, when the company had said that revenues for the quarter would be greater than $340 million. GAAP operating margin for Bruker Scientfic Instruments is now projected to exceed 18 percent, the company added. However, it did not provide a revenue figure.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.

NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.

A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.

In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.